Skin Cancer Vaccine Could Potentially Enter UK’s NHS in Next Five Years, According to Scientist Leading Experimental Drug Trial
- Groundbreaking vaccination shows potential to decrease risk of skin cancer recurrence or fatality by up to 40%
- Dr. Jane Healy, Lead Researcher, predicts vaccine’s availability by 2028
A potential breakthrough in the fight against skin cancer has emerged, with the possibility of a skin cancer vaccine becoming available through the UK’s National Health Service (NHS) within the next five years. The experimental vaccine has shown promise in reducing the risk of skin cancer recurrence or fatality by over 40%, according to scientists.
Dr. Jane Healy, lead researcher in the trial, has revealed that a larger study involving thousands of participants, including patients in the UK, is scheduled to begin next year. If successful, the vaccine could receive approval from the NHS by 2028.
‘The results of our trial were incredibly exciting as they demonstrated the effectiveness of this unique cancer vaccine. However, further validation is required with a larger sample size. If successful, this vaccine could greatly benefit patients,’ said Dr. Healy, an esteemed oncology researcher at MSD, the pharmaceutical company behind the skin cancer vaccine.
A skin cancer vaccine could be available on the NHS in the next few years, an expert has told The Mail on Sunday (stock photo)
Denial of responsibility! VigourTimes is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
Denial of responsibility! Vigour Times is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
